Floatz logo

FILGRASTIM

Elderly

The Second Hospital of Shandong Universityprotein_peptidePhase 1/2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

5 Active assets in the Elderly cohort.

Asset / SponsorPhaseRating
Keppra
Nasim Tabrizi
Phase 4BB
Metformin
Fudan University
Phase 1/2CC
Cyclophosphamide
The Second Hospital of Shandong University
Phase 1/2CC
FLUOROURACILUM
Azienda Unita Sanitaria Locale di Piacenza
D
Eloxatin
Azienda Unita Sanitaria Locale di Piacenza
D

View all 11 →

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →